Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Plos One
|
April 8, 2017
Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner
Friedrich Hahn, Adrian Schmalen, Christian Setz, et al.
Retrovirology
|
February 18, 2011
Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly
Jörg Votteler, Liane Neumann, Sabine Hahn, et al.
Antiviral Research
|
October 1, 2018
Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity
Friedrich Hahn, Corina Hutterer, Christophe Henry, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs)
Markus Wild, Jintawee Kicuntod, Lisa Seyler, et al.
International Journal of Molecular Sciences
|
December 10, 2021
Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity
Friedrich Hahn, Stuart T Hamilton, Christina Wangen, et al.
Antiviral Research
|
November 20, 2018
In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model
Eric Sonntag, Friedrich Hahn, Luca D Bertzbach, et al.
Pharmaceutics
|
February 24, 2024
An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity
DongHoon Yu, Sabrina Wagner, Martin Schütz, et al.
Viruses
|
December 9, 2020
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
Friedrich Hahn, Christina Wangen, Sigrun Häge, et al.
Oncotarget
|
June 21, 2019
Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue
Moen Sen, Friedrich Hahn, Taylor A Black, et al.
Oncotarget
|
September 7, 2019
Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue
Moen Sen, Friedrich Hahn, Taylor A Black, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Plos One
|
April 8, 2017
Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner
Friedrich Hahn, Adrian Schmalen, Christian Setz, et al.
Retrovirology
|
February 18, 2011
Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly
Jörg Votteler, Liane Neumann, Sabine Hahn, et al.
Antiviral Research
|
October 1, 2018
Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity
Friedrich Hahn, Corina Hutterer, Christophe Henry, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs)
Markus Wild, Jintawee Kicuntod, Lisa Seyler, et al.
International Journal of Molecular Sciences
|
December 10, 2021
Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity
Friedrich Hahn, Stuart T Hamilton, Christina Wangen, et al.
Antiviral Research
|
November 20, 2018
In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model
Eric Sonntag, Friedrich Hahn, Luca D Bertzbach, et al.
Pharmaceutics
|
February 24, 2024
An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity
DongHoon Yu, Sabrina Wagner, Martin Schütz, et al.
Viruses
|
December 9, 2020
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
Friedrich Hahn, Christina Wangen, Sigrun Häge, et al.
Oncotarget
|
June 21, 2019
Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue
Moen Sen, Friedrich Hahn, Taylor A Black, et al.
Oncotarget
|
September 7, 2019
Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue
Moen Sen, Friedrich Hahn, Taylor A Black, et al.
Page
of 6